Share

DRC approves 4 experimental Ebola treatments in outbreak

Democratic Republic of the Congo's health ministry says four experimental treatments have been approved for use in the Ebola virus outbreak in its northeast.

The health ministry says ZMapp, Remdesivir, Favipiravir and Regn3450 - 3471 - 3479 now can be used. Health officials began using the mAb114 treatment on August 11 on 10 patients and the ministry says they are doing well.

The ministry says there are 75 confirmed Ebola cases and 27 probable ones. Of the 59 deaths, 32 have been confirmed as Ebola since the outbreak was announced on August 1 in North Kivu province.

More than 1 600 people have been vaccinated.

Insecurity in the region, especially in what the World Health Organisation calls "red zones" where several armed groups stage attacks, is hampering efforts to treat everyone.

* Sign up to News24's top Africa news in your inbox: SUBSCRIBE TO THE HELLO AFRICA NEWSLETTER

FOLLOW News24 Africa on Twitter and Facebook

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Voting Booth
Do you think corruption-accused National Assembly Speaker Nosiviwe Mapisa-Nqakula will survive a motion of no confidence against her?
Please select an option Oops! Something went wrong, please try again later.
Results
No, her days are numbered
41% - 543 votes
Yes, the ANC caucus will protect her
59% - 773 votes
Vote
Rand - Dollar
18.88
+0.3%
Rand - Pound
23.82
+0.4%
Rand - Euro
20.38
+0.3%
Rand - Aus dollar
12.30
+0.3%
Rand - Yen
0.12
+0.3%
Platinum
908.05
0.0%
Palladium
1,014.94
0.0%
Gold
2,232.75
-0.0%
Silver
24.95
-0.1%
Brent Crude
87.00
+1.8%
Top 40
68,346
0.0%
All Share
74,536
0.0%
Resource 10
57,251
0.0%
Industrial 25
103,936
0.0%
Financial 15
16,502
0.0%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE